Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidemarie Ofner

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|March 29, 2023
Blood-Based Biomarkers as Prognostic Factors of Recurrent Disease after Radical Cystectomy: A Systematic Review and Meta-AnalysisHeidemarie Ofner, Ekaterina Laukhtina, Melanie R Hassler, et al.
Cancers|February 26, 2025
TP53 Deficiency in the Natural History of Prostate CancerHeidemarie Ofner, Gero Kramer, Shahrokh F Shariat, et al.
Current Opinion in Urology|January 2, 2025
Overlooked and underserved: how healthcare fails men in the pursuit of equityRobert J Schulz, Heidemarie Ofner, Péter Nyirády, et al.
European Urology Focus|December 31, 2023
Treatment Patterns and Real-World Outcomes for Locally Advanced or Metastatic Urothelial Cancer in the Era of ImmunotherapyMelanie R Hassler, Verena Moedlagl, Hanna Hindinger, et al.
Wiener Klinische Wochenschrift|June 4, 2025
Use of <sup>177</sup>Lu prostate-specific membrane antigen therapy in metastatic castration-resistant prostate cancer : Joint statement of the Austrian Society of Nuclear Medicine and Theranostics and the Austrian Society of Urology and AndrologySiroos Mirzaei, Gregor Schweighofer-Zwink, Heidemarie Ofner, et al.
European Urology Oncology|February 26, 2026
Positron Emission Tomography/Computed Tomography Imaging with [<sup>18</sup>F]PARPi for Precision Guidance of Poly ADP-ribose Polymerase Inhibitor Therapy in Homologous Recombination Repair Mutated and Nonmutated Metastatic Castration-resistant Prostate CancerHeidemarie Ofner, Holger Einspieler, Marius Ozenil, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 19, 2025
Does PARP1 up-regulation correlate with PSMA expression in patients with metastatic castration-resistant prostate cancer studied with [<sup>18</sup>F]PARPi and [<sup>68</sup>Ga]PSMA PET/CT?Holger Einspieler, Heidemarie Ofner, Marius Ozenil, et al.
European Urology Focus|December 13, 2025
The Influence of Urinary Diversion Type on Body Image and Decision Regret Following Radical Cystectomy: A Systematic ReviewNavid Roessler, Marcin Miszczyk, Keiichiro Miyajima, et al.
Clinical Genitourinary Cancer|January 24, 2024
Real-World Evidence of Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer: An Austrian Multicenter StudyMona Kafka, Giulia Giannini, Nastasiia Artamonova, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|March 29, 2023
Blood-Based Biomarkers as Prognostic Factors of Recurrent Disease after Radical Cystectomy: A Systematic Review and Meta-AnalysisHeidemarie Ofner, Ekaterina Laukhtina, Melanie R Hassler, et al.
Cancers|February 26, 2025
TP53 Deficiency in the Natural History of Prostate CancerHeidemarie Ofner, Gero Kramer, Shahrokh F Shariat, et al.
Current Opinion in Urology|January 2, 2025
Overlooked and underserved: how healthcare fails men in the pursuit of equityRobert J Schulz, Heidemarie Ofner, Péter Nyirády, et al.
European Urology Focus|December 31, 2023
Treatment Patterns and Real-World Outcomes for Locally Advanced or Metastatic Urothelial Cancer in the Era of ImmunotherapyMelanie R Hassler, Verena Moedlagl, Hanna Hindinger, et al.
Wiener Klinische Wochenschrift|June 4, 2025
Use of <sup>177</sup>Lu prostate-specific membrane antigen therapy in metastatic castration-resistant prostate cancer : Joint statement of the Austrian Society of Nuclear Medicine and Theranostics and the Austrian Society of Urology and AndrologySiroos Mirzaei, Gregor Schweighofer-Zwink, Heidemarie Ofner, et al.
European Urology Oncology|February 26, 2026
Positron Emission Tomography/Computed Tomography Imaging with [<sup>18</sup>F]PARPi for Precision Guidance of Poly ADP-ribose Polymerase Inhibitor Therapy in Homologous Recombination Repair Mutated and Nonmutated Metastatic Castration-resistant Prostate CancerHeidemarie Ofner, Holger Einspieler, Marius Ozenil, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 19, 2025
Does PARP1 up-regulation correlate with PSMA expression in patients with metastatic castration-resistant prostate cancer studied with [<sup>18</sup>F]PARPi and [<sup>68</sup>Ga]PSMA PET/CT?Holger Einspieler, Heidemarie Ofner, Marius Ozenil, et al.
European Urology Focus|December 13, 2025
The Influence of Urinary Diversion Type on Body Image and Decision Regret Following Radical Cystectomy: A Systematic ReviewNavid Roessler, Marcin Miszczyk, Keiichiro Miyajima, et al.
Clinical Genitourinary Cancer|January 24, 2024
Real-World Evidence of Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer: An Austrian Multicenter StudyMona Kafka, Giulia Giannini, Nastasiia Artamonova, et al.
Pageof 1